ARCHIVES

The March: Research Task Force Calls For $10 Billion NCI Budget In 5 Years

This article is from The Cancer Letter archive.

Vol. 24 No. 37 | October 2, 1998

Download PDF Visit The Full Archive

Related Articles

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

May 25, 2012

NCI Intramural Programs: Clinical Trials Support System Need Attention, report Advises DCS

December 19, 1997

Task Force Members Give Mea Culpa at Congressional Hearing

December 4, 2009

UHC Expands Risk Models To Include 25 Cancer Variables

February 24, 2012

National Cancer Institute Lists Approved Clinical Trials

January 31, 2003

Cytyc Buys Pro-Duct Health, Ductal Lavage Device Maker. TAP To Pay $875 Million To Settle Federal Civil Suit.

October 26, 2001